Authors:
BOTTINI A
BERRUTI A
BERSIGA A
BRUNELLI A
BRIZZI MP
DIMARCO B
CIRILLO F
TAMPELLINI M
BOLSI G
AGUGGINI S
BETRI E
FILIPPINI L
BERTOLI A
ALQUATI P
DOGLIOTTI L
Citation: A. Bottini et al., CYTOTOXIC AND ANTIPROLIFERATIVE ACTIVITY OF THE CMF REGIMEN ADMINISTERED IN ASSOCIATION WITH TAMOXIFEN AS PRIMARY CHEMOTHERAPY IN BREAST-CANCER PATIENTS, International journal of oncology, 13(2), 1998, pp. 385-390
Authors:
BOTTINI A
BERRUTI A
BERSIGA A
BRIZZI MP
BRUNELLI A
CIRILLO F
AGUGGINI S
BERTOLI G
ALQUATI P
DOGLIOTTI L
Citation: A. Bottini et al., INDEPENDENT ROLE OF P53 EXPRESSION AND REDUCTION IN KINETIC CELL-ACTIVITY IN PREDICTING CLINICAL COMPLETE RESPONSE (CR) TO PRIMARY CHEMOTHERAPY IN BREAST-CANCER (BC) PATIENTS, European journal of cancer, 34, 1998, pp. 466-466
Authors:
BOTTINI A
BERRUTI A
BERSIGA A
BRIZZI MP
BRUNELLI A
BETRI E
FILIPPINI L
BERTOLI G
ALQUATI L
DOGLIOTTI P
Citation: A. Bottini et al., RELATIONSHIP BETWEEN TUMOR SHRINKAGE AND CHANGES KINETIC CELL-ACTIVITY AFTER PRIMARY CHEMOTHERAPY (PC) IN BREAST-CANCER (BC) PATIENTS, European journal of cancer, 34, 1998, pp. 479-479
Authors:
BOTTINI A
BERRUTI A
BERSIGA A
BRIZZI MP
BRUNELLI A
CIRILLO F
AGUGGINI S
BERTOLI G
ALQUATI P
DOGLIOTTI L
Citation: A. Bottini et al., P53 EXPRESSION AND REDUCTION IN KINETIC CELL-ACTIVITY ARE INDEPENDENTVARIABLES PREDICTING CLINICAL COMPLETE RESPONSE (CR) TO PRIMARY CHEMOTHERAPY IN BREAST-CANCER (BC) PATIENTS, Annals of oncology, 9, 1998, pp. 21-21
Authors:
CARUSO RA
FINOCCHIARO G
BERSIGA A
FEDELE F
BETRI E
RIGOLI L
INFERRERA C
Citation: Ra. Caruso et al., CLINICOPATHOLOGICAL FEATURES OF EARLY GASTRIC-CANCER IN YOUNGER VERSUS OLDER PATIENTS IN A HIGH-INCIDENCE AREA OF NORTHERN ITALY, The Italian Journal of Gastroenterology, 29(2), 1997, pp. 138-142
Authors:
BOTTINI A
BERRUTI A
BERSIGA A
BRUNELLI A
BRIZZI MP
DIMARCO B
CIRILLO F
BOLSI G
BERTOLI G
ALQUATI P
DOGLIOTTI L
Citation: A. Bottini et al., EFFECT OF NEOADJUVANT CHEMOTHERAPY ON KI67 LABELING INDEX, C-ERBB-2 EXPRESSION AND STEROID-HORMONE RECEPTOR STATUS IN HUMAN BREAST-TUMORS, Anticancer research, 16(5B), 1996, pp. 3105-3110